Orphan drug designation given for PTC 124 for treating cystic fibrosis
Friday, December 10, 2004 11:00 IST South Plainfield, NJ
PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused on the discovery, development, and commercialization of small-molecule drugs targeting post-transcriptional control mechanisms
